Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy

Fig. 1

Flow cytometric profiling of the NCI-60 tumor cell panel. The NCI-60 tumor cell lines were analyzed for expression of 332 cell surface receptors by flow cytometry (see “Methods”). Shown is the distribution of the cell surface expression of all measured receptors as log10 mean fluorescence intensity (MFI). CNS cancer of the central nervous system, CO colon cancer, LE leukemia, LC lung cancer, BR breast cancer, ME melanoma, OV ovarian cancer, PR prostate cancer, RE renal cancer

Back to article page